- Reaction score
- 2,104
Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia - PMC
Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic ...
www.ncbi.nlm.nih.gov